Nurix logo

Nurix

San Francisco, CA

Nurix, Inc. discovers and develops therapies. The Company develops small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases.

nurixtx.com

Company Details

Founded

2012

Employees

286 employees

Raised

$545,900,032

Headquarters Location

San Francisco, CA

Public

Yes

Acquired

No

CEO

Arthur T. SandsArthur T. Sands

Founders

Arthur Weiss
Arthur Weiss
Michael Rape
Michael Rape
John Kuriyan
John Kuriyan

Company Collections

These are collections Nurix is a part of. Click on the collection name to view similar companies.

Nurix's Industries

Nurix's Tech Stack

Current Job Listings

Listing 0 of 19 job openings

    Nurix Headquarters Location

    1700 Owens Street Suite 205, San Francisco, CA 94158

    Total Amount Raised: $545,900,032

    Nurix Funding Rounds

    • Post Ipo Equity

      $175,000,000

    • Post Ipo Equity

      $40,000,000

    • Post Ipo Equity

      $160,400,000

    • Private Equity

      $120,000,000

      Private Equity Investors

      Foresite Capital
      Bain Capital Life Sciences
      Wellington Management
      EcoR1 Capital
      Third Rock Ventures
      The Column Group
      Boxer Capital
      Redmile Group

    • IPO

      Unknown

    • Series C

      $17,000,000

    • Series B

      $25,100,000

      Series B Investors

      The Column Group
      Third Rock Ventures

    • Series Unknown

      $5,300,000

      Series Unknown Investors

      The Column Group
      Third Rock Ventures

    • Seed

      $3,100,000

      Seed Investors

      The Column Group
      Third Rock Ventures
    Funding info provided by Diffbot.

    Nurix Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Nurix.

    Recent reviews